Who owns Quoin Pharmaceuticals, Ltd.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of QNRX from SEC Form 13F filings across 11 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 11 institutions disclosed 432,974 shares of Quoin Pharmaceuticals, Ltd. worth $2.1M — about 22.1% of shares outstanding; the largest disclosed holder is MILLENNIUM MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
11
13F holders
$2.1M
value, 2026 filers
22.1%
of shares outstanding (432,974 sh)
0
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of QNRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 112,323 | $543,643 | 0.0% | 5.7% | +47.3% |
| 2 | Woodline Partners LP | 76,446 | $369,999 | 0.0% | 3.9% | -52.0% |
| 3 | Aberdeen Group plc | 75,000 | $363,000 | 0.0% | 3.8% | 0.0% |
| 4 | AIGH Capital Management LLC | 70,000 | $338,800 | 0.0% | 3.6% | +37.3% |
| 5 | BOOTHBAY FUND MANAGEMENT, LLC | 59,838 | $289,616 | 0.0% | 3.1% | 0.0% |
| 6 | BARCLAYS PLC | 21,469 | $103,910 | 0.0% | 1.1% | +1551.5% |
| 7 | MORGAN STANLEY | 8,000 | $38,720 | 0.0% | 0.4% | +100.0% |
| 8 | UBS Group AG | 6,772 | $32,777 | 0.0% | 0.3% | +169.6% |
| 9 | RHUMBLINE ADVISERS | 2,332 | $11,280 | 0.0% | 0.1% | +53.3% |
| 10 | GAMMA Investing LLC | 439 | $2,125 | 0.0% | 0% | -74.5% |
| 11 | SBI Securities Co., Ltd. | 355 | $1,718 | 0.0% | 0% | +17650.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.